2020
DOI: 10.1016/j.yrtph.2020.104656
|View full text |Cite
|
Sign up to set email alerts
|

An interim internal Threshold of Toxicologic Concern (iTTC) for chemicals in consumer products, with support from an automated assessment of ToxCast™ dose response data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 122 publications
0
15
0
Order By: Relevance
“…For example, while existing oral-dose based TTCs have been compared with high-throughput external exposure estimates for risk-based priority setting [20], the new iTTC can be used with internal aggregate exposure estimates using tools like the PROduction-To-EXposure High Throughput (PROTEX-HT) model [33]. Blackburn et al, [25] have previously proposed an in vitro derived iTTC of 1 µmol/L for cosmetics; however, this proposed value was associated with several caveats and exclusions making it difficult to directly compare with the new in vivo blood iTTC derived herein, i.e., 0.10 nmol/L-blood. We are not aware of any other reported iTTCs for blood and whole-body level.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, while existing oral-dose based TTCs have been compared with high-throughput external exposure estimates for risk-based priority setting [20], the new iTTC can be used with internal aggregate exposure estimates using tools like the PROduction-To-EXposure High Throughput (PROTEX-HT) model [33]. Blackburn et al, [25] have previously proposed an in vitro derived iTTC of 1 µmol/L for cosmetics; however, this proposed value was associated with several caveats and exclusions making it difficult to directly compare with the new in vivo blood iTTC derived herein, i.e., 0.10 nmol/L-blood. We are not aware of any other reported iTTCs for blood and whole-body level.…”
Section: Discussionmentioning
confidence: 99%
“…Following the general approach for ingestion based TTCs, inhalation TTCs, e.g., [21], and dermal TTCs, e.g., [22], have also been developed. Partosch et al [23] proposed a route-to-route extrapolation method by revising the TTC to account for oral bioavailability; however, this proposed method does not adequately address the situation because it ignores other toxicokinetic (TK) processes [24,25]. The concept of an internal TTC (iTTC) has been proposed, e.g., [26][27][28] to address current limitations of the TTC so the approach can be applied more broadly including comparisons with aggregate exposure estimates.…”
Section: Introductionmentioning
confidence: 99%
“…Which compounds are important to include in biomonitoring studies? Databanks of potentially relevant compounds according to the lists published recently (Egeghy et al 2016;Ring et al 2019;Wang et al 2020) should be used, a thorough prioritization of compounds should be undertaken, and the following values should be considered and introduced in the selection process: production volumes, toxicity, and predicted exposure levels (Blackburn et al 2020;Dong et al 2019;Sobus et al 2019). From the selected list of compounds, the metabolism should be elucidated using experimental data, or predicted data from software such as QSAR Toolbox, Metaprint 2D, FAME, and Toxtree (Cronin et al 2019;Kirchmair et al 2015;Norinder et al 2018;Shapiro et al 2018;Suarez-Torres et al 2020;Tan and Kirchmair 2014;Tian et al 2018).…”
Section: Discussionmentioning
confidence: 99%
“…Current well-established human health TTC values are focused on exposures that are assessed as external oral ingestion, whereas internal exposures based on blood concentrations can be more relevant for other exposure routes, such as inhalation (Tluczkiewicz et al, 2016 ) or for substances with low oral absorption. Additionally, recent efforts in human health TTCs have focused on deriving an internal threshold of toxicological concern (iTTC) that may ultimately enable route-to-route extrapolation and TTC development for multi-route exposures (Ellison et al, 2019 ; Blackburn et al, 2020 ). Because aquatic organism exposures mainly occur through water, there is less need to address multi-exposure routes.…”
Section: Future Developments and Research Needsmentioning
confidence: 99%